GL Chemtec is a chemistry-based CRO supporting the pharmaceutical industry and broader Life Science sector. GL specializes in advanced multi-step organic synthesis, process R&D, and scale up services to support Active Pharmaceutical Ingredient (API) development, as well as advanced materials for medical devices and drug delivery.
Recent Posts
- Edgewater Capital Partners Acquires NeoGraf Solutions, LLC
- Evantic, a Portfolio Company of Edgewater Capital Partners, Acquires Vertec Polymers, Inc.
- SK Capital Partners and Edgewater Capital Partners Close Acquisition of Crystals Business from Saint-Gobain
- Edgewater Capital Partners Completes Sale of ChemQuest Chemicals to Seatex
- SK Capital Partners and Edgewater Capital Partners Announce Acquisition of Saint-Gobain’s Crystals Business
- Edgewater Capital Invests in GL CHEMTEC
- Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires MicroFab
- Edgewater Capital Partners Acquires AmeriWater
- Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires NexLogic
- Altamira MS Holdings, a Portfolio Company of Edgewater Capital Partners, Acquires Precision Fluorocarbon, LLC